These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10226945)
41. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Nagpal JK; Patnaik S; Das BR Int J Cancer; 2002 Feb; 97(5):649-53. PubMed ID: 11807792 [TBL] [Abstract][Full Text] [Related]
42. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association. Chang KC; Su IJ; Tsai ST; Shieh DB; Jin YT Oncology; 2002; 63(4):362-9. PubMed ID: 12417791 [TBL] [Abstract][Full Text] [Related]
43. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542 [TBL] [Abstract][Full Text] [Related]
44. EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan. Huang SF; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL Head Neck; 2009 Aug; 31(8):1068-77. PubMed ID: 19360742 [TBL] [Abstract][Full Text] [Related]
45. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka. Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544 [TBL] [Abstract][Full Text] [Related]
47. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Heinzel PA; Balaram P; Bernard HU Int J Cancer; 1996 Nov; 68(4):420-3. PubMed ID: 8945609 [TBL] [Abstract][Full Text] [Related]
48. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Burns JE; Baird MC; Clark LJ; Burns PA; Edington K; Chapman C; Mitchell R; Robertson G; Soutar D; Parkinson EK Br J Cancer; 1993 Jun; 67(6):1274-84. PubMed ID: 8390283 [TBL] [Abstract][Full Text] [Related]
49. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Ranasinghe AW; Warnakulasuriya KA; Johnson NW Eur J Cancer B Oral Oncol; 1993 Apr; 29B(2):147-50. PubMed ID: 8180591 [TBL] [Abstract][Full Text] [Related]
50. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188 [TBL] [Abstract][Full Text] [Related]
51. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596 [TBL] [Abstract][Full Text] [Related]
52. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Krishnamurthy J; Kannan K; Feng J; Mohanprasad BK; Tsuchida N; Shanmugam G Oral Oncol; 2001 Apr; 37(3):222-4. PubMed ID: 11287275 [TBL] [Abstract][Full Text] [Related]
53. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843 [TBL] [Abstract][Full Text] [Related]
54. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management. Fukuda M; Nakatsuka T; Kusama K; Sakashita H J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595 [No Abstract] [Full Text] [Related]
55. Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Sorensen DM; Lewark TM; Haney JL; Meyers AD; Krause G; Franklin WA Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):503-6. PubMed ID: 9158397 [TBL] [Abstract][Full Text] [Related]
56. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. Trivedy C; Warnakulasuriya KA; Tavassoli M; Steingrimsdottir H; Penhallow J; Maher R; Johnson NW J Oral Pathol Med; 1998 Feb; 27(2):72-7. PubMed ID: 9526733 [TBL] [Abstract][Full Text] [Related]
57. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Yook JI; Kim J Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054 [TBL] [Abstract][Full Text] [Related]
58. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas. Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105 [TBL] [Abstract][Full Text] [Related]
59. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related]
60. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]